Antiplatelets - BB Flashcards
4 Classes of antiplatelet agents:
- Aspirin (NSAIDs)
- ADP Blockers
- IIb/IIIa Inhibitors
- Phosphodiesterase inhibitors
Targets for antiplatelet drugs:
- Thromboxane A2 (TXA2)
- ADP
- cAMP reduction - via ADPIIb/IIIa receptor blockers
Aspirin MOA:
Inhibits cyclooxygenase (COX1+2)
Which blocks the conversion of arachadonic acid to TXA2
TXA2 is a powerful platelet activator
(COX also converts arachadonic acid to prostaglandins - which is where it gets its analgesic effects)
3 Eicosanoids groups
All converted from arachidonic acid
- Leukotrienes (by Lipoxygenase)
- Thromboxanes (COX)
- Prostaglandins (COX)
Which eicosanoid mediates many of the effects we associate with inflammation?
PGE2
Difference between Aspirin and other NSAIDs for antiplatelet activaity
Aspirin irreversibly inhibits COX-1/-2 enzyme
Other nsaids reversibly inihibit them
Means that aspirin is preferred as its activity is for the lifetime of the platelet
Examples of other NSAIDs (x5)
Ibuprofen Naproxen Indomethacin Ketorolac Diclofenac
Common uses for aspirin
Coronary disease:
- Acute MI/ Unstable angina
- Secondary prevention
Stroke:
- Acute ischaemic stroke
- Secondary prevention
Adverse effects of aspirin
- Bleeding
- Gastritis/ulcers (like all NSAIDs)
*Tinnitus
Caused by salicylate (aspirin metabolite - salicylic acid)
Alters cochlear nerve function
RARE - usually occurs with very high doses - and resolves when discontinued
*Reye’s syndrome:
* Severe adverse effect
* Liver failure and encephalopathy
* Associated with use in children - therefore not given to kids (except in kawasaki)
Thienopyridines: (name 3 drugs)
Ticlopidine
Clopidogrel
Prasugrel
Thienopyridines - mechanism of action and general uses
Irreversible P2Y12 receptor blockers
Blocks effects of ADP on platelets
USES:
- Used in aspirin allergy
- Added to aspirin in prevention of MI, Stroke
Adverse effects of thienopyridines:
Major adverse effect is bleeding
TTP - Rare dangerous side effect (strongest association with ticlopidine)
TTP as an adverse event from thienopyridines
Severe thrombocytopenia
MAHA
Neurologic abnormalitites
deficient activity of ADAMTS13 - some suggest antibodies to it
Ticagrelor - general
Cyclo-pentyl-triazolo-pyrimidine (CPTP)
Not associated with TTP
Similar mechanism of action as the theinopyridines - however different structure
Causes reversible inhibition of the P2Y12 - (ADP) receptor blockers
Unique side effect of ticagrelor
Dyspnea - mechanism unclear
also not associated with TTP
Phosphodiesterase inhibitors: (name the 2 drugs)
Dipyridamole
Cilostazole
PDE Inhibitor mechanism of action:
inhibits PDE III in platelets
- PDE breaks down cAMP
- Therefore inhibition leads to increased cAMP
- Increased cAMP leads to decreased platelet activation
Dipyridamole - mechanism of action
- PDEIII inhibitor – Inhibits platelet activation
- Also bocks adenosine uptake by cells (vasodilation)
- Adenosine is a vasodilator
- reduced uptake - raises adenosine levels in blood
- Causes vasodilation
Uses of Dipyridamole:
- Used with aspirin for stroke prevention - (antiplatelet)
- Used in chemical cardiac stress testing - (vasodilator)
- In ptx who are unable to walk on treadmill for a conventional stress test
- Vasodilation can be used to induce coronary steal
Cilostazol - mechanism of action
PDEIII inhibitor - inhibits platelet activation
Also raises cAMP in vascular smooth muscle (vasodilator)
Rarely used for antiplatelet effects - but used for vasodilator effects
Cilostazol - uses
Used as a vasodilator in peripheral arterial disease - to reduce symptoms of claudication
Rarely used for antiplatelet effects
Side effects of PDE inhibitors:
Many side effects related to vasodilation:
- Headache : meningeal vasodilation
- Flushing
- Hypotension
IIb/IIIa Receptor blockers (name the drugs)
Abciximab
Eptifibatide
Tirofiban
IIb/IIIa Receptor blockers - mechanism of action
Bind and block IIb/IIIa receptors
Abciximab - is a Fab fragment of antibody to the receptor
IIb/IIIa Receptor blockers - uses
All 3 drugs are used as:
- IV drugs in ACS and stenting
Risk of thrombocytopenia within hours of administratoin
- Must monitor platelet count after administration